Newsbenzinga
Indivior Pharmaceuticals Affirms FY2026 Sales Guidance of $1.295B-$1.365B vs $1.334B Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…